- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | FDA approves Galderma's Nemluvio to treat atopic dermatitis | ||
| Mo | The future of third-party logistics in an evolving biopharmaceutical world | ||
| Mo | Reprieve for WuXi as Biosecure vote likely pushed to 2025 | ||
| Mo | Small cell lung cancer: Navigating the global clinical trial landscape | ||
| Mo | EMA recommends expanding approval of Ofev to children and adolescents | ||
| Mo | Denmark's HTA evolution | ||
| Mo | EMA CHMP recommends Lilly's Crohn's therapy for EU approval | ||
| Mo | AbbVie to acquire Nimble Therapeutics for $200m | ||
| 13.12. | FDA accepts Sobi North America's thrombocytopenia therapy sNDA | ||
| 13.12. | Roche wins Vabysmo prefilled syringe EU approval to intensify Eylea challenge | ||
| 13.12. | Conduit and Sarborg link to optimise AI drug development | ||
| 13.12. | A novel, toothy approach to innovating randomization in clinical trials | ||
| 13.12. | AIM ImmunoTech gains Netherlands patent for post-Covid fatigue therapy | ||
| 13.12. | Flu vaccine strategy on the line as new US leaders anticipated to take charge | ||
| 12.12. | Nobel laureates 'strongly urge' Senate to oppose confirmation of RFK Jr | ||
| 12.12. | Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production | ||
| 12.12. | China NMPA approves Santhera's DMD treatment therapy | ||
| 12.12. | UK indefinitely bans puberty blockers for teenagers due to "unacceptable risk" | ||
| 12.12. | Meitheal gains US commercial rights for CABP treatment therapy | ||
| 12.12. | Transforming preventative care in the NHS | ||
| 12.12. | Sanofi's combo vaccines gain FDA fast track designation | ||
| 12.12. | How Pfizer management outplayed activist investor Starboard | ||
| 11.12. | Vifor Pharma offers £23m to NHS to resolve CMA investigation | ||
| 11.12. | Er-Kim and Ascendis' endocrine therapy agreement extended in Eurasia | ||
| 11.12. | The Innovations Shoring Up Clinical Supply Chain Integrity in the Age of Advanced Therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
